Difference between revisions of "Team:XJTLU-CHINA/Safety"

 
(14 intermediate revisions by 3 users not shown)
Line 78: Line 78:
 
             padding-bottom: 15px;
 
             padding-bottom: 15px;
 
             background-color: #3399FF;
 
             background-color: #3399FF;
 +
margin-left:-20px;
 
         }
 
         }
  
Line 231: Line 232:
 
             padding-bottom: 15px;
 
             padding-bottom: 15px;
 
             background-color: #3399FF;
 
             background-color: #3399FF;
 +
margin-left:-20px;
 
         }
 
         }
  
Line 310: Line 312:
 
             font-weight: 600;
 
             font-weight: 600;
 
             padding-top: 111px;
 
             padding-top: 111px;
 +
padding-left:10px;
 
         }
 
         }
  
Line 316: Line 319:
 
             font-weight: 600;
 
             font-weight: 600;
 
             padding-top: 5px;
 
             padding-top: 5px;
 +
padding-left:10px;
 
         }
 
         }
 +
  
 
         .navilogo{
 
         .navilogo{
Line 649: Line 654:
 
                         <ul>
 
                         <ul>
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li>
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNA thermo-meter</a></li>
+
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Chromopro-tein</a></li>
+
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">The second trial of RNAT testing</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Chromopro-tein testing</a></li>
+
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J5">Chromo-protein testing</a></li>
 
                         </ul>
 
                         </ul>
 
                     </li>
 
                     </li>
Line 670: Line 675:
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li>
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li>
 
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li>
 
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li>
 +
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J3">Achievements</a></li>
 
                         </ul>
 
                         </ul>
 
                     </li>
 
                     </li>
Line 717: Line 723:
 
                         </div>
 
                         </div>
 
                         <ul>
 
                         <ul>
                             <li><a class="jump1" href="orations:https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J1">with NYU-Shanghai</a></li>
+
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J1">with NYU-Shanghai</a></li>
                             <li><a class="jump2" href="orations:https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J2">with BIT-China</a></li>
+
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#synbio">Synbio-tech</a></li>
 +
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J2">with BIT-China</a></li>
 
                         </ul>
 
                         </ul>
 
                     </li>
 
                     </li>
Line 746: Line 753:
 
                         <ul>
 
                         <ul>
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li>
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNA thermo-meter</a></li>
+
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Chromopro-tein</a></li>
+
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Improve experiment of RNAT</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Chromopro-tein testing</a></li>
+
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J5">Chromo-protein testing</a></li>
 
                         </ul>
 
                         </ul>
 
                     </li>
 
                     </li>
Line 767: Line 774:
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li>
 
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J1">Team introduction</a></li>
 
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li>
 
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J2">Attribution</a></li>
 +
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Team#J3">Achievements</a></li>
 
                         </ul>
 
                         </ul>
 
                     </li>
 
                     </li>
Line 812: Line 820:
 
                     <li class="ZmainNavi col1">
 
                     <li class="ZmainNavi col1">
 
                         <div id="ZPrimaryNaviBg9">
 
                         <div id="ZPrimaryNaviBg9">
                             <a class="ZprimaryNavi" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaboration">Collaboration</a>
+
                             <a class="ZprimaryNavi" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations">Collaboration</a>
 
                         </div>
 
                         </div>
 
                         <ul>
 
                         <ul>
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaboration#J1">with NYU-Shanghai</a></li>
+
                             <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J1">with NYU-Shanghai</a></li>
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaboration#J2">with BIT-China</a></li>
+
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#synbio">Synbio-tech</a></li>
 +
                             <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J2">with BIT-China</a></li>
 
                         </ul>
 
                         </ul>
 
                     </li>
 
                     </li>
Line 840: Line 849:
 
     </div>
 
     </div>
 
     <div class="subNavi">
 
     <div class="subNavi">
         <p>Biosafety is probably the most controversial issue in synthetic biology field. Being responsible to others and ourselves, we have to take this seriously. </p>
+
         <p>Biosafety is probably the most controversial issue in synthetic biology. Being responsible to everyone, 2015 XJTLU team took variety of measurements to promote the safety in the lab. We reached an agreement and drafted a lab policy. We used low hazard strains to minimize the potential risks of our project.</p>
        <br/>
+
        <p>2015 XJTLU team took variety of measures to promote the safety in the lab. We reached an agreement in a discussion and drafted a lab policy. For our project, using low hazard strains minimizes the potential risks of our project.</p>
+
 
     </div>
 
     </div>
 
</div>
 
</div>
Line 861: Line 868:
 
         <div class="ruleImgText">
 
         <div class="ruleImgText">
 
             <p style="font-size: 25px; text-align: center">Policy</p>
 
             <p style="font-size: 25px; text-align: center">Policy</p>
            <br/>
+
             <p style="font-size: 15px; text-align: center">(Sorry for only Chinese version.)</p>
            <br/>
+
             <p>The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as some tips. For instance, “having a good mood” is documented as the top one because keeping your mind clean, clear, positive and free is usually a good way to ensure the correctness and safety of experiments. In order to guarantee the implementation of the policy, we chose one of our team members as a supervisor.</p>
             <p>(Sorry for only Chinese version provided.) </p>
+
            <br/>
+
             <p>The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as tips. For instances, “having a good mood” is documented as the top one because keeping your mind clean, clear, positive and free is usually a good way to ensure the correctness of experiments and the safety. In order to guarantee the implementation of the policy, we chose one of our team members as a supervisor.</p>
+
 
         </div>
 
         </div>
  
Line 880: Line 884:
 
         <div class="lv0">
 
         <div class="lv0">
 
             <div class="lv1">
 
             <div class="lv1">
                 <h2 STYLE="text-align: center; font-size: 55px; background-color: #3300FF";>Q & A</h2>
+
                 <h2 STYLE="text-align: center; font-size: 55px; background-color: #191970; color: #FFFFFF";>Q & A</h2>
 
             </div>
 
             </div>
 
         </div>
 
         </div>
Line 893: Line 897:
 
                 <div class="lv2" >
 
                 <div class="lv2" >
 
                     <h3>Researcher Safety</h3>
 
                     <h3>Researcher Safety</h3>
                     <div class="lv2-1">Escherichia coli, as an engineering bacterium is the cell line that we normally work with. As an engineering bacterium, it has been documented as a non-hazard microbe and extensively used for decades. The carcinogenic experiment reagents, such as Ethidium bromide the DNA dye, had been replaced by less harmful reagents before initiating the project.  Moreover, we follow the rules and firmly believe that the safety is always priority to our project.</div>
+
                     <div class="lv2-1"><i>Escherichia coli</i>, as an engineering bacterium, is the cell line that we normally work with. As an engineering bacterium, it has been documented as a non-hazard microbe and extensively used for decades. The carcinogenic experiment reagents, such as Ethidium bromide the DNA dye, had been replaced by less harmful reagents before initiating the project.  Moreover, we followed the rules and firmly believe that the safety is always priority to our project.</div>
 
                     <br/>
 
                     <br/>
 
                     <h3>Public Safety</h3>
 
                     <h3>Public Safety</h3>
                     <div class="lv2-1">Our project is only a demonstrated project and is not involved in any direct contact between the bacteria and public. The key is the visual effect caused by the microbes instead of the products of bacteria or bacteria itself. i.e. the biothermomap may only use for non-commercial and non-profit purpose and the bacteria would not be spread out and used by other institutions, except in our lab.</div>
+
                     <div class="lv2-1">Our project is only a demonstrated project and is not involved in any direct contact between the bacteria and the public. The key is the visual effect caused by the microbes instead of the products of bacteria or bacteria itself. i.e. the biothermomap may only use for non-commercial and non-profit purpose and the bacteria would not be spread out and used by other institutions, except in our lab.</div>
 
                     <br/>
 
                     <br/>
 
                     <h3>Environmental Safety</h3>
 
                     <h3>Environmental Safety</h3>
                     <div class="lv2-1">No. Theoretically, after the demonstration of our project, our bacteria would be disposed of properly and immediately. No further investigations are required. Even if there are experimental bacteria accidentally enter natural environment, they are highly unlikely to pose a threat given the overloaded bacteria and the harmless nature of themselves.</div>
+
                     <div class="lv2-1">No. Theoretically, after the demonstration of our project, our bacteria would be disposed of properly and immediately. No further investigations are required. Even if there are experimental bacteria accidentally entering natural environment, they are highly unlikely to pose a threat given the overloaded bacteria and the harmless nature of themselves.</div>
 
                     <br/>
 
                     <br/>
 
                 </div>
 
                 </div>
Line 917: Line 921:
 
                 <h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h2>
 
                 <h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h2>
 
                 <div class="lv2" >
 
                 <div class="lv2" >
                     <div class="lv2-1">No. we do not use any new BioBrick parts. All BioBrick parts are derived from the previous iGEM team or the literature and which all has been expressed in E. coli previously and no hazardous conclusion was drawn. The only difference is that integrating various protein genes into one construct forms a relatively complicated bacteria internal environment, which is inclined to weaken the cells.</div>
+
                     <div class="lv2-1">No. we did not use any new BioBrick parts. All BioBrick parts were derived from the previous iGEM team or the literature and which all had been expressed in <i>E. coli</i> previously and no hazardous conclusion was drawn. The only difference is that integrating various protein genes into one construction forms a relatively complicated bacteria internal environment, which is inclined to weaken the cells.</div>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
Line 934: Line 938:
 
                 <h2>Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?</h2>
 
                 <h2>Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?</h2>
 
                 <div class="lv2" >
 
                 <div class="lv2" >
                     <div class="lv2-1">No. To be honest, there is NO any biosafety-related group, committee, or review board at our institution. This is probably a universal answer for Chinese biological institutions. We wouldn’t dare to affirm that Chinese government completely neglects the biosafety issue but can tell that the economic benefits always outweigh the costs on the biosafety in the view of a vast majority of proprietors. Fortunately, in our lab, there is a strict safety assessment procedure devised by the lab managers and which is fully capable of ensuring the safety of researcher. All in all, biosafety is an oversight that we normally have in China. We are obligatory on improving the understanding of the importance of biosafety and in order to change the situation in a large scale, we are hereby looking forward to the assistance of Chinese government.</div>
+
                     <div class="lv2-1">No. To be honest, there is NO any biosafety-related group, committee, or review board at our institution. This is probably a universal answer for Chinese biological institutions. We wouldn’t dare to affirm that Chinese government completely neglects the biosafety issue but can tell that the economic benefits always outweigh the costs on the biosafety in the view of a vast majority of proprietors. Fortunately, in our lab, there is a strict safety assessment procedure devised by the lab managers and which is fully capable of ensuring the safety of the researchers. All in all, biosafety is an oversight that we normally have in China. We are obligatory on improving the understanding of the importance of biosafety and in order to change the situation in a large scale, we are hereby looking forward to the assistance of Chinese government.</div>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
Line 971: Line 975:
 
<div class="footer">
 
<div class="footer">
 
     <div class="footerBg">
 
     <div class="footerBg">
         <div class="container" style="text-align: center">
+
         <div class="container" style="text-align: center; padding-top: 40px;">
 
             <img class="logo" src="https://static.igem.org/mediawiki/2015/d/da/LogoXJTLU15.png" height="53">
 
             <img class="logo" src="https://static.igem.org/mediawiki/2015/d/da/LogoXJTLU15.png" height="53">
 
             <img class="logo" src="https://static.igem.org/mediawiki/2015/9/96/Logo2XJTLU15.png" height="50">
 
             <img class="logo" src="https://static.igem.org/mediawiki/2015/9/96/Logo2XJTLU15.png" height="50">
             <img class="logo" src="https://static.igem.org/mediawiki/2015/e/e3/%E6%B3%93%E8%BF%85%E7%A7%91%E6%8A%80Synbio_Technologies_Logo.png" height="50" style="margin-top:60px;">
+
             <img class="logo" src="https://static.igem.org/mediawiki/2015/e/e3/%E6%B3%93%E8%BF%85%E7%A7%91%E6%8A%80Synbio_Technologies_Logo.png" height="50" >
 
             <br/>
 
             <br/>
 
             <img class="logo" src="https://static.igem.org/mediawiki/2015/4/41/AgilentXJTLU15.png" height="50" style="margin-top:60px;">
 
             <img class="logo" src="https://static.igem.org/mediawiki/2015/4/41/AgilentXJTLU15.png" height="50" style="margin-top:60px;">

Latest revision as of 16:16, 4 October 2015

Safety

Saftey



Policy

(Sorry for only Chinese version.)

The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as some tips. For instance, “having a good mood” is documented as the top one because keeping your mind clean, clear, positive and free is usually a good way to ensure the correctness and safety of experiments. In order to guarantee the implementation of the policy, we chose one of our team members as a supervisor.


Q & A


Would any of your project ideas raise safety issues in terms of:

Researcher Safety

Escherichia coli, as an engineering bacterium, is the cell line that we normally work with. As an engineering bacterium, it has been documented as a non-hazard microbe and extensively used for decades. The carcinogenic experiment reagents, such as Ethidium bromide the DNA dye, had been replaced by less harmful reagents before initiating the project. Moreover, we followed the rules and firmly believe that the safety is always priority to our project.

Public Safety

Our project is only a demonstrated project and is not involved in any direct contact between the bacteria and the public. The key is the visual effect caused by the microbes instead of the products of bacteria or bacteria itself. i.e. the biothermomap may only use for non-commercial and non-profit purpose and the bacteria would not be spread out and used by other institutions, except in our lab.

Environmental Safety

No. Theoretically, after the demonstration of our project, our bacteria would be disposed of properly and immediately. No further investigations are required. Even if there are experimental bacteria accidentally entering natural environment, they are highly unlikely to pose a threat given the overloaded bacteria and the harmless nature of themselves.



Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?

No. we did not use any new BioBrick parts. All BioBrick parts were derived from the previous iGEM team or the literature and which all had been expressed in E. coli previously and no hazardous conclusion was drawn. The only difference is that integrating various protein genes into one construction forms a relatively complicated bacteria internal environment, which is inclined to weaken the cells.


Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project?

No. To be honest, there is NO any biosafety-related group, committee, or review board at our institution. This is probably a universal answer for Chinese biological institutions. We wouldn’t dare to affirm that Chinese government completely neglects the biosafety issue but can tell that the economic benefits always outweigh the costs on the biosafety in the view of a vast majority of proprietors. Fortunately, in our lab, there is a strict safety assessment procedure devised by the lab managers and which is fully capable of ensuring the safety of the researchers. All in all, biosafety is an oversight that we normally have in China. We are obligatory on improving the understanding of the importance of biosafety and in order to change the situation in a large scale, we are hereby looking forward to the assistance of Chinese government.


Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?

An approach is to establish a risk assessment section in our Wiki page to allow diverse groups to comment and point out the potential risks. It cannot be denied that there is a possibility creating some sorts of superbugs unexpectedly. But most of the biohazards are foreseeable and predictable. Different groups may look at biosafety problems from completely different perspectives, which is conducive to discovering the risks on the early stage.